Commentary--goodbye M(C)ID! Hello MID, where do you come from?

Affiliations

Comment

Holger J Schünemann et al. Health Serv Res. 2005 Apr.

. 2005 Apr;40(2):593-7.

doi: 10.1111/j.1475-6773.2005.00374.x.

¹ Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.

No abstract available

Comment on

A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease.
Wyrwich KW, Tierney WM, Babu AN, Kroenke K, Wolinsky FD. Wyrwich KW, et al. Health Serv Res. 2005 Apr;40(2):577-91. doi: 10.1111/j.1475-6773.2005.00373.x. Health Serv Res. 2005. PMID: 15762908 Free PMC article.

1. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR, Clinical Significance Consensus Meeting. “Methods to Explain the Clinical Significance of Health Status Measures.”. Mayo Clinic Proceedings. 2002;77(4):371–83. - PubMed
1. Guyatt G, Montori V, Devereaux PJ, Schünemann H, Bhandari M. “Patients at the Centre: In Our Practice, and in Our Use of Language.”. ACP Journal Club. 2004;140:A-11. - PubMed
1. Jaeschke R, Singer J, Guyatt GH. “Measurement of Health Status. Ascertaining the Minimal Clinically Important Difference.”. Controlled Clinical Trials. 1989;10(4):407–15. - PubMed
1. Juniper EF, Guyatt GH, Willan A, Griffith LE. “Determining a Minimal Important Change in a Disease-Specific Quality of Life Questionnaire.”. Journal of Clinical Epidemiology. 1994;47(1):81–7. - PubMed
1. Lassere MN, van derHeijde D, Johnson KR. “Foundations of the Minimal Clinically Important Difference for Imaging.”. Journal of Rheumatology. 2001;28:890–1. - PubMed